MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1,880 crore, investors were disappointed by the profitability miss. Brokerage Nomura maintained its ‘Buy’ rating, highlighting MedPlus’ long-term growth potential driven by its store expansion strategy.
Reliance Industries eyes growth boost from O2C, retail and Jio businesses
Reliance Industries has reported a significant growth in revenue and profits for the September quarter. The oil-to-chemicals segment has led this growth while retail segment